Evidence map›Paper›PMID 27807076›Full record

ArticleEMBO molecular medicine2016

A POGLUT1 mutation causes a muscular dystrophy with reduced Notch signaling and satellite cell loss.

Emilia Servián-Morilla, Hideyuki Takeuchi, Tom V Lee, Jordi Clarimon, Fabiola Mavillard, Estela Area-Gómez, Eloy Rivas, Jose L Nieto-González, Maria C Rivero, Macarena Cabrera-Serrano and 14 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 4 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 4 syntheses or guidelines pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Distinct O-Linked Glycosylation Systems in Signaling and Immune Regulation.International journal of molecular sciences · 2026
    Review
  7. Article
  8. DifferentialProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Muscle-specific increased expression ofProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Review
  11. NOTCH2 mutation in centronuclear myopathy: Beyond the scope.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 10 institutions in 3 countries.

Emilia Servián-MorillaNeuromuscular Disorders Unit, Department of Neurology, Instituto de Biomedicina de Sevilla, Hospital U. Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.
Hideyuki TakeuchiDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY, USA.
Tom V LeeDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Jordi ClarimonCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Fabiola MavillardCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Estela Area-GómezDepartment of Neurology, Columbia University Medical Center, New York, NY, USA.
Eloy RivasDepartment of Pathology, Instituto de Biomedicina de Sevilla, Hospital U. Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.
Jose L Nieto-GonzálezCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Maria C RiveroCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Macarena Cabrera-SerranoNeuromuscular Disorders Unit, Department of Neurology, Instituto de Biomedicina de Sevilla, Hospital U. Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.
Leonardo Gómez-SánchezCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Jose A Martínez-LópezCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Beatriz EstradaCentro Andaluz de Biología del Desarrollo (CABD), Universidad Pablo Olavide, Sevilla, Spain.
Celedonio MárquezNeuromuscular Disorders Unit, Department of Neurology, Instituto de Biomedicina de Sevilla, Hospital U. Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.
Yolanda MorgadoDepartment of Neurology, Hospital U. Valme, Sevilla, Spain.
Xavier Suárez-CalvetLaboratori de Malalties Neuromusculars, Institut de Recerca de HSCSP, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Guillermo PitaHuman Genotyping Unit-CeGen, Spanish National Cancer Research Centre, Madrid, Spain.
Anne BigotUPMC Univ Paris 06, INSERM UMRS974, CNRS FRE3617, Center for Research in Myology, Sorbonne Universités, Paris, France.
Eduard GallardoLaboratori de Malalties Neuromusculars, Institut de Recerca de HSCSP, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Rafael Fernández-ChacónCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Michio HiranoDepartment of Neurology, Columbia University Medical Center, New York, NY, USA.
Robert S HaltiwangerDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY, USA.
Hamed Jafar-NejadDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Carmen ParadasNeuromuscular Disorders Unit, Department of Neurology, Instituto de Biomedicina de Sevilla, Hospital U. Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain cparadas@us.es.ORCID 0000-0002-6917-2236
Biomedical Research Networking Center on Neurodegenerative Diseases · ESColumbia University Irving Medical Center · USUniversitat Autònoma de Barcelona · ESBaylor College of Medicine · USInstituto de Biomedicina de Sevilla · ESStony Brook University · USCentre National de la Recherche Scientifique · FRCentro Andaluz de Biología del Desarrollo · ESHospital Universitario de Valme · ESSpanish National Cancer Research Centre · ES

Funding

The North American Mitochondrial Disease Consortium (NAMDC)U54NS078059 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HIRANO, MICHIO · 2011 to 2023
$17.5M
Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Cale Whitworth · 2014 to 2026
$13.5M
O-Glycosylation of Epidermal Growth Factor-like MotifsR01GM061126 · NIGMS · UNIVERSITY OF GEORGIA · PI HALTIWANGER, ROBERT S. · 2001 to 2021
$9.1M
Steps towards a paternal gene activation therapy for Angelman syndromeU54HD083092 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI LEE, BRENDAN, NELSON, DAVID LOREN · 2014 to 2019
$7.8M
Fine-Tuning the Notch Signaling Pathway via O-GlucosylationR01GM084135 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI JAFAR-NEJAD, HAMED · 2008 to 2017
$2.6M
Molecular Pathogenesis and Treatment of MNGIER01HD056103 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HIRANO, MICHIO · 2010 to 2014
$1.9M
Endoplasmic Reticulum Mitochondrial membranes in Alzheimer's diseaseK01AG045335 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI AREA GOMEZ, ESTELA · 2014 to 2018
$567k
NIA NIH HHS K01 AG045335NICHD NIH HHS R01 HD056103NICHD NIH HHS U54 HD083092NIGMS NIH HHS R01 GM061126NIGMS NIH HHS R01 GM084135NIH HHS P40 OD018537NINDS NIH HHS U54 NS078059
6 · The paper itself

Abstract

Skeletal muscle regeneration by muscle satellite cells is a physiological mechanism activated upon muscle damage and regulated by Notch signaling. In a family with autosomal recessive limb-girdle muscular dystrophy, we identified a missense mutation in POGLUT1 (protein O-glucosyltransferase 1), an enzyme involved in Notch posttranslational modification and function. In vitro and in vivo experiments demonstrated that the mutation reduces O-glucosyltransferase activity on Notch and impairs muscle development. Muscles from patients revealed decreased Notch signaling, dramatic reduction in satellite cell pool and a muscle-specific α-dystroglycan hypoglycosylation not present in patients' fibroblasts. Primary myoblasts from patients showed slow proliferation, facilitated differentiation, and a decreased pool of quiescent PAX7

Indexed as

MutationSignal TransductionBiopsyGlucosyltransferasesGlycosylationGlycosyltransferasesHumansMusclesMuscular DystrophiesReceptors, NotchSatellite Cells, Skeletal MuscleSequence Analysis, DNASpainGlucosyltransferasesGlycosyltransferasesPOGLUT1 protein, humanReceptors, Notchmuscular dystrophyNotchO‐glycosylationPOGLUT1satellite cell

Identifiers

PMID27807076
PMCPMC5090660
OpenAlexW2529943124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.